(Q45871503)

17 December 2017

title

Intravenous administration of an AAV-2 vector for the expression of factor IX in mice and a dog model of hemophilia B. (English)

1 reference

17 December 2017

main subject

hemophilia

0 references

coagulation factor IX

0 references

hemophilia B

0 references

author name string

T C Harding

1

1 reference

17 December 2017

K E Koprivnikar

2

1 reference

17 December 2017

G H Tu

3

1 reference

17 December 2017

N Zayek

4

1 reference

17 December 2017

S Lew

5

1 reference

17 December 2017

A Subramanian

6

1 reference

17 December 2017

A Sivakumaran

7

1 reference

17 December 2017

D Frey

8

1 reference

17 December 2017

K Ho

9

1 reference

17 December 2017

M J VanRoey

10

1 reference

17 December 2017

T C Nichols

11

1 reference

17 December 2017

D A Bellinger

12

1 reference

17 December 2017

S Yendluri

13

1 reference

17 December 2017

J Waugh

14

1 reference

17 December 2017

J McArthur

15

1 reference

17 December 2017

G Veres

16

1 reference

17 December 2017

B A Donahue

17

1 reference

17 December 2017

publication date

1 January 2004

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

11

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

204-213

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302142

exact match

0 references

cites work

Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Persistent expression of canine factor IX in hemophilia B canines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Sustained correction of bleeding disorder in hemophilia B mice by gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Improved hepatic gene transfer by using an adeno-associated virus serotype 5 vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Introns increase transcriptional efficiency in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Heterologous introns can enhance expression of transgenes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

A generic intron increases gene expression in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Intronless mRNA transport elements may affect multiple steps of pre-mRNA processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Rate limiting steps of AAV transduction and implications for human gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

inferred from DOI database lookup

7 January 2021

based on heuristic

Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302142

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302142

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017